Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment
- 1 June 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 69 (6) , 360-368
Abstract
The heavy impact of obesity on the development and progression of cardiovascular disease has sparked sustained efforts to uncover the mechanisms linking excess adiposity to vascular dysfunction. In addition to its well-established role in maintaining vascular homeostasis, the endothelium has been increasingly recognized as a key player in modulating healthy adipose tissue expansion in response to excess calories by providing adipocyte precursors and driving angiogenesis. When this increased storage need is unmet, excessive deposition of fat occurs at ectopic locations, including perivascular adipose tissue (PVAT). PVAT is in intimate contact with the vessel wall, hence affecting vascular function and structure. In lean individuals, PVAT exerts anticontractile and anti-inflammatory activities to protect the vasculature. In obesity, instead, these beneficial properties are lost and PVAT releases inflammatory mediators, promotes oxidative stress, and contributes to vascular dysfunction. The underlying mechanisms elicited by these outside-in signals include resistance to the vasodilator actions of insulin and activation of endothelin (ET)-1-mediated vasoconstriction. A number of adipokines and gut hormones, which are important modulators of food intake, energy balance, glucose and lipid metabolism, insulin sensitivity, and inflammation, have also positive vascular actions. This feature makes them promising tools for targeting both the metabolic and cardiovascular complications of obesity, a view supported by recent large-scale clinical trials indicating that novel drugs for type 2 diabetes with cardiovascular potential may translate into clinically significant benefits. There is, therefore, real hope that unleashing the power of fat- and gut-derived substances might provide effective dual-action therapies for obesity and its complications.Keywords
This publication has 98 references indexed in Scilit:
- Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complicationsMolecular Aspects of Medicine, 2013
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese AdultsJAMA, 2012
- Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic targetBritish Journal of Pharmacology, 2012
- The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium‐dependent NO signallingBritish Journal of Pharmacology, 2011
- Enhanced endothelin-1 system activity with overweight and obesityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Conversion of vascular endothelial cells into multipotent stem-like cellsNature Medicine, 2010
- Proinflammatory Phenotype of Perivascular AdipocytesCirculation Research, 2009
- Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- An Integrated View of Insulin Resistance and Endothelial DysfunctionEndocrinology and Metabolism Clinics of North America, 2008
- Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesityInternational Journal of Obesity, 2008